Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
about
Whole-Body Vibration as a Modality for the Rehabilitation of Peripheral Neuropathies: Implications for Cancer Survivors Suffering from Chemotherapy-Induced Peripheral NeuropathyThe effect of glutamine intake on complications of colorectal and colon cancer treatment: A systematic reviewChemotherapy-induced peripheral neurotoxicity and complementary and alternative medicines: progress and perspectiveAmerican Cancer Society Colorectal Cancer Survivorship Care GuidelinesMechanisms of chemotherapy-induced behavioral toxicitiesChemotherapy-induced peripheral neurotoxicity: a critical analysisThe Rehabilitation of Oncological Patients Presenting NeuropathiesAntineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicityModeling chemotherapeutic neurotoxicity with human induced pluripotent stem cell-derived neuronal cellsTherapeutic Effects of Phytochemicals and Medicinal Herbs on Chemotherapy-Induced Peripheral NeuropathyCoadministration of indomethacin and minocycline attenuates established paclitaxel-induced neuropathic thermal hyperalgesia: Involvement of cannabinoid CB1 receptorsAnti-allodynic effect of Buja in a rat model of oxaliplatin-induced peripheral neuropathy via spinal astrocytes and pro-inflammatory cytokines suppressionSTX140, but not paclitaxel, inhibits mammary tumour initiation and progression in C3(1)/SV40 T/t-antigen transgenic miceTargeting neuroprotection as an alternative approach to preventing and treating neuropathic painPaclitaxel-induced increase in mitochondrial volume mediates dysregulation of intracellular Ca2+ in putative nociceptive glabrous skin neurons from the ratSR 57746A/xaliproden, a non-peptide neurotrophic compound: prospects and constraints for the treatment of nervous system diseases.The addition of granulocyte-colony stimulating factor shifts the dose limiting toxicity and markedly increases the maximum tolerated dose and activity of the kinesin spindle protein inhibitor SB-743921 in patients with relapsed or refractory lymphomProteasome inhibitors in glioblastomaHerbal Medicine AC591 Prevents Oxaliplatin-Induced Peripheral Neuropathy in Animal Model and Cancer Patients.Predicting acute and persistent neuropathy associated with oxaliplatin.Oxaliplatin neurotoxicity involves peroxisome alterations. PPARγ agonism as preventive pharmacological approach.Changes in ovarian function in premenopausal women with breast cancer undergoing adjuvant TC (docetaxel and cyclophosphamide) chemotherapy during a brief period of amenorrhea around the last chemotherapy cycle.The Role of Supportive Therapy in the Era of Modern Adjuvant Treatment - Current and Future Tools.Antitumor Activity of IMC-038525, a Novel Oral Tubulin Polymerization Inhibitor.Antinociceptive Effect of Memantine and Morphine on Vincristine-induced Peripheral Neuropathy in Rats.Sensitization of radio-resistant prostate cancer cells with a unique cytolethal distending toxin.Paclitaxel-induced hyposensitivity to nociceptive chemical stimulation in mice can be prevented by treatment with minocycline.Phase I and pharmacologic study of BNP7787, a novel chemoprotector in patients with advanced non-small cell lung cancerGyejigachulbu-Tang Relieves Oxaliplatin-Induced Neuropathic Cold and Mechanical Hypersensitivity in Rats via the Suppression of Spinal Glial Activation.Chemotherapy-induced polyneuropathy. Part I. Pathophysiology.Serotonergic mechanism of the relieving effect of bee venom acupuncture on oxaliplatin-induced neuropathic cold allodynia in rats.Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy.Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: a review.Increased interleukin-6 activity associated with painful chemotherapy-induced peripheral neuropathy in women after breast cancer treatment.Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-A Calmare®) for chemotherapy-induced peripheral neuropathy.Anti-nociceptive effect of kinin B₁ and B₂ receptor antagonists on peripheral neuropathy induced by paclitaxel in mice.Effects of goshajinkigan, hachimijiogan, and rokumigan on mechanical allodynia induced by Paclitaxel in miceHerbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review.Calcium and magnesium prophylaxis for oxaliplatin-related neurotoxicity: is it a trade-off between drug efficacy and toxicity?α7 Nicotinic Receptor Promotes the Neuroprotective Functions of Astrocytes against Oxaliplatin Neurotoxicity
P2860
Q26771423-5B7D3DAF-9F50-4C18-B3A3-92D274A57D6BQ26772187-29CA3E05-DCC8-478A-ABA4-3944B3C08C94Q26777967-B8800C3E-07AC-4330-8C7F-C3106AC7432BQ26782671-F2F533C1-53B6-4B58-A111-21BA8BBEA6B3Q26998870-7A160BAB-B4D6-4BE6-BA7B-0170E98454A3Q27010318-23385CDF-BDBD-4DA2-9D50-ABAAD8BA36A0Q27024318-1D6CA03B-616C-444E-B123-F555AB49B074Q27305830-B9CE8523-DD26-4F25-A683-D61D25981C32Q27314983-1CB9D570-0D80-4CD3-BC3B-7F4FB26E1C66Q28075341-CDF0B2D5-DF1A-48B5-A5FF-4F1E29F5CFB9Q28315016-1477DB26-4205-480F-8FF5-D12977A2A5A9Q28468568-125D34A8-A2D2-4C67-9A7C-B7D5A6EA2421Q28536340-8438C651-A5B9-483D-A978-66D673D16EFDQ28820780-2F587CC7-BE96-4DA6-99B1-038873CB8EB3Q29248252-E85CF7F2-549F-4696-A996-CD1FBF960E86Q30318977-154D07A8-0D15-4983-BF40-D4B3758E74DBQ33420259-16382F06-37CC-4E90-9C5A-C7991C085533Q33598931-0E83D370-ED15-4A70-8DD2-8CC9358609FCQ33770708-02BA6811-D27B-4895-9131-A95FAB65CD36Q33841734-EA67F7F5-2CDA-493F-9B2B-279692520731Q33921641-F28BAB91-E1BF-4D95-BF1D-BF089F7469D6Q33955356-D6299E4D-8454-4893-9D09-5955971E0808Q34095827-6A2F3427-8B32-44E2-8B9A-1A983E53F711Q34111215-7AECA7F4-F18A-4CF4-8838-9B0DD53F4250Q34112816-23F10223-A3BC-46AC-A56C-FB8F1E2EF4A0Q34221837-EE4D133C-BA28-431A-869C-A44F1BA94393Q34384978-1D52A597-C793-4FB5-B166-DDC7FBB60FDEQ34594899-F4FBB0AF-5AFE-4923-A263-B90B8438EEDDQ34610876-ABD3DC12-ECC0-4BEE-BE57-94C9BB3905EBQ34653461-5BAE1C26-C846-4794-BA4B-F5795CB03D62Q34968046-71D78BD7-1E5B-4E37-9682-4933217D06B2Q35138445-A0304086-6D24-45F8-9A1F-265C7E1CC9F3Q35143365-5B6519F1-92E5-4238-86B4-4078E20DBB61Q35202129-F9BEB159-FDE3-4A2D-AD54-E18AA57B6852Q35248852-DAE83DD7-AB0A-4232-9649-602167A77ED0Q35287537-3FE0239D-A85C-461A-9304-E9AC6192AECDQ35402526-08D13489-7C0D-4754-96DF-D5DE17C3E8E9Q35596252-F0F70E46-6D2D-4519-B67D-7DAE0AE340FFQ35642335-23540766-68C8-4A4A-97D1-33ADAEF0EF08Q35749490-6C83B5F2-B7AC-453F-B61A-E85C51F2E6D9
P2860
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
@ast
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
@en
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
@nl
type
label
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
@ast
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
@en
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
@nl
prefLabel
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
@ast
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
@en
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
@nl
P2093
P1476
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
@en
P2093
Axel Grothey
Charles Loprinzi
Debra Barton
Lisa Kottschade
Sherry Wolf
P304
P356
10.1016/J.EJCA.2008.04.018
P577
2008-06-18T00:00:00Z